MedTrace Logo

Mood and Excess Weight Gain in Adolescent Pregnancy

NCT03086161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2021-02-04

No results posted yet for this study

Summary

50-70% of adolescents gain too much weight during pregnancy, and this excess gain significantly increases their risk of high postpartum weight retention and long-term obesity. In this randomized controlled pilot study, the investigators are evaluating the feasibility and acceptability of a relatively brief interpersonal psychotherapy program for reducing excess gestational weight gain during adolescent pregnancy. Compared to treatment-as-usual prenatal care delivered in an adolescent maternity clinic, the investigators will estimate the added benefit of an interpersonal psychotherapy program's effectiveness for reducing excess gestational weight gain, improving maternal postpartum insulin sensitivity, and decreasing maternal and infant adiposity.

Conditions

  • Obesity
  • Adolescent Development
  • Pregnancy Related
  • Insulin Sensitivity
  • Interpersonal Relations
  • Stress

Interventions

BEHAVIORAL

Interpersonal Psychotherapy

Six individual 1-hour sessions delivered over the course of pregnancy to address interpersonal problems areas that may lead to emotional eating, physical inactivity, and increased stress during pregnancy, which are drivers of excess weight gain in pregnancy

BEHAVIORAL

Treatment-as-usual

Routine prenatal care as part of multidisciplinary adolescent pregnancy clinic, including medical (ob/gyn), nutrition, and social work

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Children's Hospital Colorado

    collaborator OTHER

  • Colorado State University

    lead OTHER

Principal Investigators

  • Lauren B Shomaker, PhD · Colorado State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-23
Primary Completion
2020-01-17
Completion
2020-01-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086161 on ClinicalTrials.gov